TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicentre Randomised Control Trial of Point-of-treatment (Clinic-based) Xpert MTB/RIF Assay
Brief Summary: Xpert MTB/RIF assay is a novel automated molecular tool for the diagnosis of TB. Xpert can detect TB genetic material in sputum samples as well as test for genetic resistance to rifampicin providing results within 2 hours. Xpert received WHO endorsement in December 2010. There is limited data on the impact of Xpert on time-to-treatment and TB-related patient morbidity in primary care clinics. No studies have yet evaluated Xpert performed at the point-of-treatment (POT) i.e. in primary care clinic location. The investigators hypothesize that one sputum GeneXpert MTB/RIF assay performed at the POT will improve time-to-diagnosis, time-to-treatment and TB related patient morbidity for patients with suspected TB presenting to primary level TB clinics in high HIV prevalent settings.


Options:
A: Arm Label: Antiretroviral therapy, tuberculosis; Type: N/A; Interventions: N/A
B: Arm Label: LAM plus standard care; Type: EXPERIMENTAL; Interventions: Device: Urine LAM strip test | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Urine LAM strip test; Assigned to Arm(s): LAM plus standard care
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Interventional; Type: EXPERIMENTAL; Interventions: Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) | Intervention Type: DIAGNOSTIC_TEST; Name: Xpert MTB/RIF Ultra (Ultra); Assigned to Arm(s): Interventional
D: Arm Label: Xpert MTB/RIF; Type: EXPERIMENTAL; Interventions: Procedure: Xpert MTB/RIF assay | Arm Label: Sputum smear microscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Smear microscopy | Intervention Type: PROCEDURE; Name: Xpert MTB/RIF assay; Assigned to Arm(s): Xpert MTB/RIF | Intervention Type: PROCEDURE; Name: Smear microscopy; Assigned to Arm(s): Sputum smear microscopy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicentre Randomised Control Trial of Point-of-treatment (Clinic-based) Xpert MTB/RIF Assay
Brief Summary: Xpert MTB/RIF assay is a novel automated molecular tool for the diagnosis of TB. Xpert can detect TB genetic material in sputum samples as well as test for genetic resistance to rifampicin providing results within 2 hours. Xpert received WHO endorsement in December 2010. There is limited data on the impact of Xpert on time-to-treatment and TB-related patient morbidity in primary care clinics. No studies have yet evaluated Xpert performed at the point-of-treatment (POT) i.e. in primary care clinic location. The investigators hypothesize that one sputum GeneXpert MTB/RIF assay performed at the POT will improve time-to-diagnosis, time-to-treatment and TB related patient morbidity for patients with suspected TB presenting to primary level TB clinics in high HIV prevalent settings.


Options:
A: Arm Label: Xpert MTB/RIF; Type: EXPERIMENTAL; Interventions: Procedure: Xpert MTB/RIF assay | Arm Label: Sputum smear microscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Smear microscopy | Intervention Type: PROCEDURE; Name: Xpert MTB/RIF assay; Assigned to Arm(s): Xpert MTB/RIF | Intervention Type: PROCEDURE; Name: Smear microscopy; Assigned to Arm(s): Sputum smear microscopy
B: Arm Label: Smear; Type: ACTIVE_COMPARATOR; Interventions: Other: Smear | Arm Label: GeneXpert; Type: EXPERIMENTAL; Interventions: Other: Xpert | Intervention Type: OTHER; Name: Xpert; Assigned to Arm(s): GeneXpert | Intervention Type: OTHER; Name: Smear; Assigned to Arm(s): Smear
C: Arm Label: LAM plus standard care; Type: EXPERIMENTAL; Interventions: Device: Urine LAM strip test | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Urine LAM strip test; Assigned to Arm(s): LAM plus standard care
D: Arm Label: GeneXpert; Type: ACTIVE_COMPARATOR; Interventions: Other: GeneXpert, Other: LED Microscopy | Arm Label: LED Microscopy; Type: ACTIVE_COMPARATOR; Interventions: Other: LED Microscopy | Intervention Type: OTHER; Name: GeneXpert; Assigned to Arm(s): GeneXpert | Intervention Type: OTHER; Name: LED Microscopy; Assigned to Arm(s): GeneXpert, LED Microscopy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicentre Randomised Control Trial of Point-of-treatment (Clinic-based) Xpert MTB/RIF Assay
Brief Summary: Xpert MTB/RIF assay is a novel automated molecular tool for the diagnosis of TB. Xpert can detect TB genetic material in sputum samples as well as test for genetic resistance to rifampicin providing results within 2 hours. Xpert received WHO endorsement in December 2010. There is limited data on the impact of Xpert on time-to-treatment and TB-related patient morbidity in primary care clinics. No studies have yet evaluated Xpert performed at the point-of-treatment (POT) i.e. in primary care clinic location. The investigators hypothesize that one sputum GeneXpert MTB/RIF assay performed at the POT will improve time-to-diagnosis, time-to-treatment and TB related patient morbidity for patients with suspected TB presenting to primary level TB clinics in high HIV prevalent settings.


Options:
A: Arm Label: Xpert MTB/RIF; Type: EXPERIMENTAL; Interventions: Procedure: Xpert MTB/RIF assay | Arm Label: Sputum smear microscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Smear microscopy | Intervention Type: PROCEDURE; Name: Xpert MTB/RIF assay; Assigned to Arm(s): Xpert MTB/RIF | Intervention Type: PROCEDURE; Name: Smear microscopy; Assigned to Arm(s): Sputum smear microscopy
B: Arm Label: Urgent ART; Type: EXPERIMENTAL; Interventions: Other: Urgent ART | Arm Label: Early ART; Type: ACTIVE_COMPARATOR; Interventions: Other: Early ART | Intervention Type: OTHER; Name: Urgent ART; Assigned to Arm(s): Urgent ART | Intervention Type: OTHER; Name: Early ART; Assigned to Arm(s): Early ART
C: Arm Label: LAM plus standard care; Type: EXPERIMENTAL; Interventions: Device: Urine LAM strip test | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Urine LAM strip test; Assigned to Arm(s): LAM plus standard care
D: Arm Label: Xpert MTB/RIF®, Determine TB LAM, Chest X-ray; Type: EXPERIMENTAL; Interventions: Device: Xpert MTB/RIF®, Determine TB LAM, Chest X-ray, Drug: ART (Atripla, Truvada, Efavirenz, Combivir), Drug: Rifampin, isoniazid, pyrazinamide, ethambutol | Arm Label: Rifampin, isoniazid, pyrazinamide, ethambutol; Type: EXPERIMENTAL; Interventions: Drug: ART (Atripla, Truvada, Efavirenz, Combivir), Drug: Rifampin, isoniazid, pyrazinamide, ethambutol | Intervention Type: DEVICE; Name: Xpert MTB/RIF®, Determine TB LAM, Chest X-ray; Assigned to Arm(s): Xpert MTB/RIF®, Determine TB LAM, Chest X-ray | Intervention Type: DRUG; Name: ART (Atripla, Truvada, Efavirenz, Combivir); Assigned to Arm(s): Rifampin, isoniazid, pyrazinamide, ethambutol, Xpert MTB/RIF®, Determine TB LAM, Chest X-ray | Intervention Type: DRUG; Name: Rifampin, isoniazid, pyrazinamide, ethambutol; Assigned to Arm(s): Rifampin, isoniazid, pyrazinamide, ethambutol, Xpert MTB/RIF®, Determine TB LAM, Chest X-ray

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Eicosapentaenoic Acid (EPA)/ Docosahexaenoic Acid (DHA) Supplementation on Cognitive Control in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Brief Summary: Forty children with and 40 children without Attention deficit Hyperactivity Disorder (ADHD) receive Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) or placebo via a dietary intervention. Cognitive control functions are measured with functional Magnetic Resonance Imaging (MRI) before and after the intervention. Behavioural change is monitored with behavioural scales.


Options:
A: Arm Label: ADHD active; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Eicosapentaenoic acid / Docosahexaenoic acid | Arm Label: ADHD Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo dietary intervention (MUFA) in ADHD group | Arm Label: Active Healthy control; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Eicosapentaenoic acid / Docosahexaenoic acid | Arm Label: Healthy placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo dietary intervention (MUFA) in healthy control group | Intervention Type: DIETARY_SUPPLEMENT; Name: Eicosapentaenoic acid / Docosahexaenoic acid; Assigned to Arm(s): ADHD active | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo dietary intervention (MUFA) in ADHD group; Assigned to Arm(s): ADHD Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Eicosapentaenoic acid / Docosahexaenoic acid; Assigned to Arm(s): Active Healthy control | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo dietary intervention (MUFA) in healthy control group; Assigned to Arm(s): Healthy placebo
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Extended Release Methylphenidate (OROS-Methylphenidate) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Extended Release Methylphenidate (OROS-Methylphenidate) | Intervention Type: DRUG; Name: Extended Release Methylphenidate (OROS-Methylphenidate); Assigned to Arm(s): 1, 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Phosphatidylserine-Omega3 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Colored cellulose tainted with fishy odor | Intervention Type: DIETARY_SUPPLEMENT; Name: Phosphatidylserine-Omega3; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Colored cellulose tainted with fishy odor; Assigned to Arm(s): 2
D: Arm Label: Wheat germ oil; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Wheat germ oil | Arm Label: docosahexaenoic acid; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: docosahexaenoic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: docosahexaenoic acid; Assigned to Arm(s): docosahexaenoic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: Wheat germ oil; Assigned to Arm(s): Wheat germ oil

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hemoglobin and Iron Recovery Study
Brief Summary: The purpose of this study is to investigate the effect of daily iron supplements after blood donation on time to recovery of hemoglobin and iron stores. The study will also determine whether the effect of iron supplements on time to recovery is different in men and women, in older vs. younger donors (\<60 years old vs. at least 60 years old) and in donors with replete vs. diminished pre-donation iron stores.


Options:
A: Arm Label: Iron supplements; Type: EXPERIMENTAL; Interventions: Dietary Supplement: ferrous gluconate | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: ferrous gluconate; Assigned to Arm(s): Iron supplements
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: GB (Florestor) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: GRALB | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: GC (placebo) | Intervention Type: DRUG; Name: GB (Florestor); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: GRALB; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: GC (placebo); Assigned to Arm(s): 3
C: Arm Label: Folic Acid and Iron; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Folic Acid and Iron | Arm Label: Folic Acid; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Folic Acid | Arm Label: Multivitamins, Folic Acid, and Iron; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Multivitamins, Folic Acid, and Iron | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins, Folic Acid, and Iron; Assigned to Arm(s): Multivitamins, Folic Acid, and Iron | Intervention Type: DIETARY_SUPPLEMENT; Name: Folic Acid and Iron; Assigned to Arm(s): Folic Acid and Iron | Intervention Type: DIETARY_SUPPLEMENT; Name: Folic Acid; Assigned to Arm(s): Folic Acid
D: Arm Label: Ferrous sulfate; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: ferrous sulfate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: ferrous sulfate; Assigned to Arm(s): Ferrous sulfate | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: How Can Health Care Help Female Breastcancer Patients Reduce Their Stress Symptoms? A Randomized Intervention Study With Stepped-care
Brief Summary: The purpose of this study within Caring sciences is to identify women with breast cancer who have stress symptoms and to offer these women appropriate care to reduce stress and increase well-being. This will be achieved by

1. Studying the prevalence of stress related symptoms in female patients with breast cancer
2. Testing the use of two short screening instruments to identify women at risk for developing long-standing stress symptoms
3. Studying the level and intensity of stress management interventions required to achieve increased well-being, using a stepped-care approach.
4. Studying the effects of interventions based on cognitive behavior therapy, delivered individually or in a group format.

The hypothesis is that half of the individuals assigned to a low intensity intervention will be significantly improved after treatment. For individuals who continue to have symptoms after low intensity treatment it is hypothesized that continued treatment in a group setting with high intensity interventions will be more cost-effective. In addition the assumption is that reduction of stress symptoms in women with breast cancer will lead to a reduction in socio-economic costs.


Options:
A: Arm Label: Stress management Individual format; Type: EXPERIMENTAL; Interventions: Behavioral: Stress management, in two steps | Arm Label: Stress management Group format; Type: EXPERIMENTAL; Interventions: Behavioral: Stress management, in two steps | Intervention Type: BEHAVIORAL; Name: Stress management, in two steps; Assigned to Arm(s): Stress management Group format, Stress management Individual format
B: Arm Label: Mindfulness-Based Cognitive Therapy (MBCT); Type: EXPERIMENTAL; Interventions: Other: Mindfulness-Based Cognitive Therapy | Arm Label: Waitlist control group; Type: OTHER; Interventions: Other: Waitlist | Intervention Type: OTHER; Name: Mindfulness-Based Cognitive Therapy; Assigned to Arm(s): Mindfulness-Based Cognitive Therapy (MBCT) | Intervention Type: OTHER; Name: Waitlist; Assigned to Arm(s): Waitlist control group
C: Arm Label: Guided Imagery and Progressive Muscle Relaxation; Type: EXPERIMENTAL; Interventions: Other: Guided Imagery and Progressive Muscle Relaxation | Intervention Type: OTHER; Name: Guided Imagery and Progressive Muscle Relaxation; Assigned to Arm(s): Guided Imagery and Progressive Muscle Relaxation
D: Intervention Type: BEHAVIORAL; Name: Mindfulness Meditation-Based Stress Reduction; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Supportive-Expressive Group Therapy; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial
Brief Summary: The objective of this study is to conduct a prospective randomized controlled trial of robotic-assisted versus conventional laparoscopy for the treatment of endometriosis.


Options:
A: Arm Label: Laparoscopic Radical Hysterectomy; Type: EXPERIMENTAL; Interventions: Procedure: Laparoscopic Radical Hysterectomy + pelvic lymphadenectomy | Arm Label: Abdominal radical hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal radical hysterectomy | Intervention Type: PROCEDURE; Name: Laparoscopic Radical Hysterectomy + pelvic lymphadenectomy; Assigned to Arm(s): Laparoscopic Radical Hysterectomy | Intervention Type: PROCEDURE; Name: Abdominal radical hysterectomy; Assigned to Arm(s): Abdominal radical hysterectomy
B: Arm Label: Robotic surgery; Type: EXPERIMENTAL; Interventions: Procedure: Robotic surgery | Arm Label: Abdominal surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal surgery | Intervention Type: PROCEDURE; Name: Robotic surgery; Assigned to Arm(s): Robotic surgery | Intervention Type: PROCEDURE; Name: Abdominal surgery; Assigned to Arm(s): Abdominal surgery
C: Arm Label: Robotic Surgery; Type: EXPERIMENTAL; Interventions: Procedure: Robotic surgery | Arm Label: Laparoscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic Surgery | Intervention Type: PROCEDURE; Name: Robotic surgery; Assigned to Arm(s): Robotic Surgery | Intervention Type: PROCEDURE; Name: Laparoscopic Surgery; Assigned to Arm(s): Laparoscopy
D: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: robotic laparoscopic sacrocolpopexy | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic Sacral Colpopexy | Intervention Type: PROCEDURE; Name: robotic laparoscopic sacrocolpopexy; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Laparoscopic Sacral Colpopexy; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial
Brief Summary: The objective of this study is to conduct a prospective randomized controlled trial of robotic-assisted versus conventional laparoscopy for the treatment of endometriosis.


Options:
A: Arm Label: Robotic Surgery; Type: EXPERIMENTAL; Interventions: Procedure: Robotic surgery | Arm Label: Laparoscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic Surgery | Intervention Type: PROCEDURE; Name: Robotic surgery; Assigned to Arm(s): Robotic Surgery | Intervention Type: PROCEDURE; Name: Laparoscopic Surgery; Assigned to Arm(s): Laparoscopy
B: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: robotic laparoscopic sacrocolpopexy | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic Sacral Colpopexy | Intervention Type: PROCEDURE; Name: robotic laparoscopic sacrocolpopexy; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Laparoscopic Sacral Colpopexy; Assigned to Arm(s): 1
C: Arm Label: Laparoscopic Abdominal Sacrocolpopexy (LASC); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard laparoscopic abdominal sacrocolpopexy | Arm Label: Robotic Assisted Laparoscopic (RASC); Type: EXPERIMENTAL; Interventions: Procedure: Robotic assisted laparoscopic abdominal sacrocolpopexy | Intervention Type: PROCEDURE; Name: Robotic assisted laparoscopic abdominal sacrocolpopexy; Assigned to Arm(s): Robotic Assisted Laparoscopic (RASC) | Intervention Type: PROCEDURE; Name: Standard laparoscopic abdominal sacrocolpopexy; Assigned to Arm(s): Laparoscopic Abdominal Sacrocolpopexy (LASC)
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Total Abdominal Radical Hysterectomy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Total Laparoscopic or Robotic Radical Hysterectomy | Intervention Type: PROCEDURE; Name: Total Abdominal Radical Hysterectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Total Laparoscopic or Robotic Radical Hysterectomy; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Drug Eluting Balloon in peripherAl inTErvention: the DEBATE SFA Study
Brief Summary: The purpose of this study is to evaluate the efficacy of drug-eluting balloon angioplasty followed by nitinol stent implantation versus nitinol stent implantation in superficial femoral artery and popliteal artery stenosis.


Options:
A: Intervention Type: DRUG; Name: Balloon Angioplasty with or without drug administration; Assigned to Arm(s): N/A
B: Arm Label: Laser atherectomy and drug-coated balloon; Type: ACTIVE_COMPARATOR; Interventions: Device: Laser Atherectomy (Spectranetics CE marked peripheral laser atherectomy catheters (including Turbo Elite®), Turbo-Booster® and Turbo Tandem™ Systems | Arm Label: Drug eluting Ballon PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: Laser Atherectomy (Spectranetics CE marked peripheral laser atherectomy catheters (including Turbo Elite®), Turbo-Booster® and Turbo Tandem™ Systems | Intervention Type: DEVICE; Name: Laser Atherectomy (Spectranetics CE marked peripheral laser atherectomy catheters (including Turbo Elite®), Turbo-Booster® and Turbo Tandem™ Systems; Assigned to Arm(s): Drug eluting Ballon PTA, Laser atherectomy and drug-coated balloon
C: Arm Label: ENERGY-Population; Type: N/A; Interventions: Device: Pro Kinetic Energy bare metal stent | Intervention Type: DEVICE; Name: Pro Kinetic Energy bare metal stent; Assigned to Arm(s): ENERGY-Population
D: Arm Label: standard PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: nitinol stent implantation | Arm Label: DEB; Type: EXPERIMENTAL; Interventions: Device: paclitaxel-eluting balloon angioplasty followed by nitinol stent implantation | Intervention Type: DEVICE; Name: paclitaxel-eluting balloon angioplasty followed by nitinol stent implantation; Assigned to Arm(s): DEB | Intervention Type: DEVICE; Name: nitinol stent implantation; Assigned to Arm(s): standard PTA

Answer: D